Latest Advanced Prostate Cancer News

//Latest Advanced Prostate Cancer News

Yervoy ( Ipilimumab ) Useless When Used By Itself

Yervoy (ipilimumab) alone doesn’t help treat advanced prostate cancer patients. Yervoy activates the immune system by going after the CTLA-4 protein receptor that slows immune-system activity. But prostate cancer responds to Yervoy by increasing two other immune [...]

By | April 10th, 2017|Categories: Advanced Prostate Cancer|0 Comments

Selective Androgen Receptor Degraders May Become New Treatment for Castration Resistant Prostate Cancer

New molecules called selective androgen receptor degraders (SARDs) might be helpful in fighting advanced prostate cancer, according to an industry-sponsored study presented April 1, at the 99th annual meeting of the Endocrine Society. "If successful [...]

By | April 7th, 2017|Categories: Advanced Prostate Cancer|0 Comments

Estrogen As New Prostate Cancer Treatment

Fetal estrogen estetrol, also called E4, is being tested in the Netherlands as a treatment for advanced prostate cancer. "E4 for the treatment of prostate cancer would offer a new and affordable option compared to [...]

By | April 3rd, 2017|Categories: Advanced Prostate Cancer, advanced prostate cancer support group|0 Comments

Androgen Deprivation Therapy (ADT) may not be the best way to fight advanced prostate cancer

Researchers from the University and the Sichuan Antibiotics Industrial Institute in China have discovered a novel treatment for advanced prostate cancer. For over forty years, ADT has been the foundation of advanced stage prostate cancer [...]

By | March 15th, 2017|Categories: Advanced Prostate Cancer, Hormone Therapy, Uncategorized|0 Comments

New Way to Do PET Scans

  There’s a better way to do a PET scan, by using radiotracer fluciclovine (fluorine-18; F-18) (Journal of Nuclear Medicine, March 2017) According to researcher Ashesh B. Jani, MD, Winship Cancer Institute of Emory University, [...]

By | March 6th, 2017|Categories: Advanced Prostate Cancer, Imaging, NaF-PET/CT, Radiation, Uncategorized|0 Comments

Relugolix – Oral Hormone Treatment for advanced prostate cancer

There's a new Phase 3 clinical trial for an oral medication, taken one time per day, that will reduce testosterone for advanced prostate cancer. Myovant Sciences is testing their new drug, called Relugolix in a trial [...]

By | March 2nd, 2017|Categories: Advanced Prostate Cancer, Hormone Therapy, Uncategorized|0 Comments